#National Institutes of Health

If passed, the law would boost liver disease research and create a national strategy to tackle non-alcoholic steatohepatitis.

The vaccine demonstrated 95% efficacy in an ongoing Phase III trial.

Recovery and death rates were similar in people treated with the anti-malaria drug or a placebo.

A carbohydrate called heparan sulfate, found on cell surfaces, may help the new coronavirus infects cells.

The study asks whether certain approved therapies or late-stage investigational drugs show promise against COVID-19.

It’s part of a $234 million federal initiative to improve COVID-19 testing among vulnerable populations.

New findings may explain why some people with COVID-19 develop more severe disease.

The trial is evaluating an investigational vaccine from Janssen that may require only one shot.

Researchers hope to combine gene editing with a less toxic stem cell transplant. Findings may apply to cancer and other illnesses.

Products based on broadly neutralizing antibodies could be used in HIV treatment and prevention.

The bill includes support for HIV research, the Ryan White HIV/AIDS programs and more. A date for the full House review has not been set.

The molecular biologist was the first to clone HIV, and she helped prove that the virus causes AIDS. She also researched cancer genetics.

This finding offers important insight into research on HIV cure therapies.

Based on antibodies isolated from llamas, researchers engineered an antibody that prevented SARS-CoV-2 from entering cells.

A recent NIH study found that adults have a much higher viral suppression rate than youth.

As a result, researchers in Spain are testing whether HIV med Truvada, often used as PrEP, can also prevent COVID-19.